Benefits: Helps reduce stubborn fat, supports cardiovascular and immune health, promotes digestion, and contributes to long-term metabolic and weight management
[4] [5] The standard of care remains disease-modifying antirheumatic drugs (DMARDs), including conventional synthetic DMARDs like methotrexate as first-line therapy, with escalation to biological DMARDs or targeted synthetic DMARDs if disease activity remains inadequately controlled, following a treat-to-target approach
Taking berberine with food rather than on empty stomach reduces GI side effects, though this may compromise absorption
These findings indicate that GLP-1R activation specifically inhibits GSDMD-mediated microglial pyroptosis, a finding consistently replicated in subsequent in vitro experiments (Song et al., 2022)
Emmert M, Meier F, Pisch F, Sander U
A medical necessity statement from the prescriber tying the medication to obesity treatment If you dont have a primary care doc whos familiar with GLP-1 prior auths, this is the time to find one